Purpose:
The objective of the study is to compare the safety and gastrointestinal tolerability of ferric maltol oral suspension and ferrous sulfate oral liquid in children and adolescents aged 2 years to 17 years, and assess the safety and tolerability of ferric maltol oral suspension in children 1 month to less than 2 years, in the treatment of iron deficiency anemia during the 12 weeks treatment period.
What to Expect:
Participation in the anemia / iron deficiency study lasts approximately 12 weeks and includes visits to the study site. Qualifying participants may be compensated for their time and travel.
Eligibility Criteria:
Participant must:
Length / Duration:
Participation in this comparative study lasts approximately 12 weeks and includes follow up visits to the study site and supervised dosing by parent/legal guardian for children/adolescents throughout the treatment period and recorded on a dosing diary.
Location:
3229 Hillsdale Lane, Kissimmee, Florida 34741, United States
Who should you contact:
Recruitment Department: (407) 350-3979
Tell us a little bit about yourself. We will contact you for additional information to determine your eligibility for current and future studies.
3229 Hillsdale Lane, Kissimmee, Florida 34741, United States
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.